AVIVAGEN to Present at The LD 500 Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / Avivagen: (TSXV:VIV)(OTCQB:VIVXF), a life sciences company with a natural, approved and patented alternative to antibiotics, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 12:40 PM PST/9:40 AM EST. Kym Anthony, Chief Executive Officer will be presenting to a live audience.
Register here: https://ld-micro-conference.events.issuerdirect.com/
“We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space.” stated Chris Lahiji, Founder of LD.
The LD 500 will take place on September 1st through the 4th.
View AVIVAGEN’S profile here: http://www.Id/micro.com/profile/VIV
Profiles powered by LD Micro – News Compliments of Accesswire
About AVIVAGEN:
We are a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance.
About LD Micro
Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.
What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.
The upcoming “500” in September is the Company’s most ambitious project yet, and the first event that is accessible to everyone.
For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.
Contact:
Name: Drew Basek
Phone: 416-540-0733
Address:100 Sussex Drive
Ottawa, Ontario
Canada K1A 0R6
Email: d.basek@avivagen.com
SOURCE: Avivagen.com via LD Micro
View source version on accesswire.com:
https://www.accesswire.com/601582/AVIVAGEN-to-Present-at-The-LD-500-Virtual-Conference
